Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Thioridazine
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Hamilton Health Sciences | Juravinski Cancer Centre Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 26, 2014
Lead Product(s) : Thioridazine
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Hamilton Health Sciences | Juravinski Cancer Centre Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable